F.D.A. Says Pfizer Vaccine’s Benefits Outweigh Key Risks in Children 5 to 11. Clinical Trials, Coronavirus (2019-nCoV), Vaccination and Immunization, Children and Childhood, Coronavirus Risks and Safety Concerns, Pfizer Inc, BioNTech SE, Food and Drug Administration